{"id":"https://openalex.org/W2490434149","doi":"https://doi.org/10.1158/1538-7445.am2016-2885","title":"Abstract 2885: Somatic mutation of STAT3 leads to the preferential Th17 differentiation in human na\u00efve CD4-positive cells and favor TCR-mediated proliferation","display_name":"Abstract 2885: Somatic mutation of STAT3 leads to the preferential Th17 differentiation in human na\u00efve CD4-positive cells and favor TCR-mediated proliferation","publication_year":2016,"publication_date":"2016-07-15","ids":{"openalex":"https://openalex.org/W2490434149","doi":"https://doi.org/10.1158/1538-7445.am2016-2885","mag":"2490434149"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2016-2885","doi":"https://doi.org/10.1158/1538-7445.am2016-2885","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-2885","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5104356111","display_name":"Ramona Crescenzo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ramona Crescenzo","raw_affiliation_strings":["Weill Cornell Medicine, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Cornell Medicine, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027244648","display_name":"Valentina Fragliasso","orcid":"https://orcid.org/0000-0002-4189-0316","observed_orcids":["https://orcid.org/0000-0002-4189-0316"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Valentina Fragliasso","raw_affiliation_strings":["Weill Cornell Medicine, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Cornell Medicine, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024430820","display_name":"Marcello Gaudiano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marcello Gaudiano","raw_affiliation_strings":["Weill Cornell Medicine, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Cornell Medicine, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081278891","display_name":"Marco Pizzi","orcid":"https://orcid.org/0000-0003-4006-7317","observed_orcids":["https://orcid.org/0000-0003-4006-7317"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marco Pizzi","raw_affiliation_strings":["Weill Cornell Medicine, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Cornell Medicine, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006640724","display_name":"Giorgio Inghirami","orcid":"https://orcid.org/0000-0001-5566-0864","observed_orcids":["https://orcid.org/0000-0001-5566-0864","https://orcid.org/0000-0002-5298-6516"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Giorgio Inghirami","raw_affiliation_strings":["Weill Cornell Medicine, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Cornell Medicine, New York, NY","institution_ids":["https://openalex.org/I4387153466"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4387153466"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"76","issue":"14_Supplement","first_page":"2885","last_page":"2885"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.8682000041007996,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.8682000041007996,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.07970000058412552,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.04749999940395355,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/th17-differentiation","display_name":"Th17 cell differentiation","score":0.8820000290870667},{"id":"https://openalex.org/keywords/naive-cd4-t-cells","display_name":"naive CD4+ T cells","score":0.8790000081062317},{"id":"https://openalex.org/keywords/anaplastic-large-cell-lymphoma","display_name":"anaplastic large cell lymphoma","score":0.9769999980926514},{"id":"https://openalex.org/keywords/rorgammat","display_name":"ROR\u03b3t","score":0.7860000133514404},{"id":"https://openalex.org/keywords/il23r","display_name":"IL23R","score":0.8980000019073486},{"id":"https://openalex.org/keywords/il-17","display_name":"IL-17","score":0.8960000276565552},{"id":"https://openalex.org/keywords/il-21","display_name":"IL-21","score":0.578000009059906},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.5770000219345093},{"id":"https://openalex.org/keywords/transforming-growth-factor-beta","display_name":"TGF-beta","score":0.8029999732971191},{"id":"https://openalex.org/keywords/jak1-stat3-signaling","display_name":"JAK1/STAT3 signaling","score":0.7390000224113464},{"id":"https://openalex.org/keywords/gata3","display_name":"GATA3","score":0.6629999876022339},{"id":"https://openalex.org/keywords/t-bet","display_name":"T-bet","score":0.45899999141693115},{"id":"https://openalex.org/keywords/t-cell-proliferation","display_name":"T cell proliferation","score":0.5090000033378601},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.5370000004768372}],"concepts":[{"id":"https://openalex.org/C74737994","wikidata":"https://www.wikidata.org/wiki/Q18031207","display_name":"RAR-related orphan receptor gamma","level":4,"score":0.705668568611145},{"id":"https://openalex.org/C2778923194","wikidata":"https://www.wikidata.org/wiki/Q14912019","display_name":"STAT3","level":3,"score":0.6955066919326782},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5577490925788879},{"id":"https://openalex.org/C102037460","wikidata":"https://www.wikidata.org/wiki/Q18025464","display_name":"GATA3","level":4,"score":0.5253514647483826},{"id":"https://openalex.org/C156730664","wikidata":"https://www.wikidata.org/wiki/Q23308590","display_name":"Interleukin 23","level":4,"score":0.49834489822387695},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4867711067199707},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4415213167667389},{"id":"https://openalex.org/C114684123","wikidata":"https://www.wikidata.org/wiki/Q419458","display_name":"CD3","level":4,"score":0.43639498949050903},{"id":"https://openalex.org/C148738053","wikidata":"https://www.wikidata.org/wiki/Q210861","display_name":"Cellular differentiation","level":3,"score":0.42966705560684204},{"id":"https://openalex.org/C47348012","wikidata":"https://www.wikidata.org/wiki/Q99486570","display_name":"Interleukin 17","level":3,"score":0.42286744713783264},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3948304057121277},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3050481677055359},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.299058198928833},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.2770323157310486},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2403038740158081},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.19076630473136902},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.16572439670562744},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12020432949066162},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2016-2885","doi":"https://doi.org/10.1158/1538-7445.am2016-2885","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2016-2885","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2102305118","https://openalex.org/W4254608707","https://openalex.org/W2150025175","https://openalex.org/W2564343389","https://openalex.org/W2225160522","https://openalex.org/W2191902360","https://openalex.org/W2735417632","https://openalex.org/W1968235930","https://openalex.org/W4391598934","https://openalex.org/W1975476768"],"abstract_inverted_index":{"Abstract":[0],"Intro:":[1],"Mature":[2],"Th17":[3,19,41,61,64,100,348,458],"lymphocytes":[4],"play":[5],"a":[6,40,54,85,148,246,321,346],"key":[7],"role":[8,417],"in":[9,110,125,168,263,269,310,361,372,421,427,460],"the":[10,46,58,78,95,99,127,131,311,339,362,382,389,392,396,403,412,416,423,429,456,473,478],"host":[11,128,132,400],"defenses":[12],"against":[13],"bacteria":[14],"and":[15,27,37,50,57,75,77,130,144,164,183,206,252,298,354,376,415,426,465],"fungi":[16],"although":[17],"unchecked":[18],"activation":[20,79,384],"can":[21,387],"lead":[22],"to":[23,52,245,255,289,293,320,345,410,455],"autoimmune":[24],"disorders,":[25],"inflammation":[26],"cancer.":[28],"The":[29,63,367],"engagement":[30],"of":[31,48,60,80,87,98,159,189,242,249,304,313,342,350,364,370,385,391,398,418,433,452,472,477],"CD4+":[32,152,156],"na\u00efve":[33,157,352,462],"T-cells":[34,353],"via":[35,198],"IL6":[36,172,283],"TGF\u03b2":[38,178],"favors":[39],"differentiation":[42,65,349,459],"program,":[43],"which":[44,83],"requires":[45,66],"presence":[47,312,363],"IL21":[49,174],"IL23":[51],"reach":[53],"complete":[55],"maturation":[56],"maintenance":[59],"phenotype.":[62],"multiple":[67],"lineage":[68],"defining":[69],"transcription":[70],"factors":[71,88],"(i.e.":[72,89],"ROR\u03b1,":[73],"ROR\u03b3t,":[74,90],"STAT3)":[76],"STAT3":[81,195,201,243,274,300,309,331,343,356,378,386,453],"signaling,":[82],"regulates":[84],"plethora":[86],"IL23R),":[91],"is":[92,120],"required":[93],"for":[94,481],"full":[96],"execution":[97],"program.":[101],"We":[102],"have":[103],"recently":[104],"shown":[105],"that":[106,223,338,381],"JAK1/STAT3":[107],"activating":[108],"mutations":[109],"Anaplastic":[111],"Large":[112],"cell":[113,264],"Lymphomas":[114],"(ALCL)":[115],"are":[116,408],"oncogenic,":[117],"but":[118],"it":[119],"unknown":[121],"their":[122,358],"protumorigenic":[123],"contribution":[124],"modulating/derailing":[126],"microenviroment":[129],"responses.":[133],"Methods:":[134],"50":[135],"FFPE":[136],"ALCLs":[137],"were":[138,162,196,208,236,261,287],"investigated":[139],"with":[140,307],"pSTAT3,":[141],"GATA3,":[142],"ROR\u03b3":[143,229,371],"T-Bet":[145],"antibodies":[146],"using":[147],"dual":[149],"color":[150],"approach.":[151],"CD62L+":[153],"CD25-":[154],"CD45RAhi":[155],"cells":[158,306,394,401,464],"healthy":[160],"donor":[161],"sorted":[163],"cultured":[165,278],"(7":[166],"days)":[167],"KBM":[169],"(IL23":[170],"(25ng/ml),":[171,173,175],"IL1\u03b2":[176],"(12,5ng/ml),":[177],"(5ng/ml)":[179],"+":[180,282,284],"1%":[181],"FBS":[182],"anti-CD3/CD28":[184,285],"beads":[185],"(1:50).":[186],"Forced":[187,240],"expressions":[188],"WT":[190,299,330],"or":[191,266,329],"mutated":[192,377],"Y640F":[193],"(YF)":[194],"achieved":[197],"lentiviral":[199],"transduction.":[200],"qRTPCR,":[202],"luciferase":[203,324],"assay,":[204],"ATPlite,":[205],"ELISA":[207],"used":[209],"as":[210],"readouts":[211],"on":[212],"samples":[213,235],"collected":[214],"at":[215],"day":[216],"7":[217],"post-transduction.":[218],"Results:":[219],"IHC":[220],"stains":[221],"showed":[222],"pSTAT3+":[224,373],"ALCL":[225,234,374],"preferentially":[226,237],"co-expressed":[227],"nuclear":[228],"(p<000.1).":[230],"Conversely,":[231],"GATA3+":[232],"ALK-":[233],"STAT3-/ROR\u03b3-":[238],"(12/14).":[239],"expression":[241,248,325,341,369],"led":[244,319],"higher":[247,323],"IL23R,":[250],"ROR\u03b3t":[251],"IL17,":[253],"compared":[254],"controls":[256,297],"cells.":[257,301,333],"No":[258],"statistically":[259],"differences":[260],"seen":[262],"proliferation":[265],"metabolic":[267],"levels":[268,326],"these":[270],"conditions.":[271],"Na\u00efve":[272],"YF":[273,308,355],"CD4":[275,351],"cells,":[276],"when":[277],"w/o":[279],"IL2":[280],"(100U/ml)":[281],"beads,":[286],"able":[288],"efficiently":[290],"proliferate":[291],"up":[292],"20":[294],"days":[295],"overcome":[296],"Lastly,":[302],"transfection":[303],"HEK293T":[305],"an":[314],"IL17":[315],"promoter":[316],"reporter":[317],"cassette,":[318],"significant":[322],"than":[327],"control":[328],"transfected":[332],"Conclusions:":[334],"Our":[335],"data":[336],"demonstrated":[337],"ectopic":[340],"leads":[344,454],"robust":[347],"sustains":[357],"growth":[359,425],"overtime":[360],"TCR":[365],"signaling.":[366],"preferential":[368,457],"(ALK+":[375],"ALK-ALCL)":[379],"suggest":[380],"deregulated":[383],"regulate":[388],"plasticity":[390],"neoplastic":[393,404],"favoring":[395],"recruitment":[397],"inflammatory":[399,431],"within":[402],"lesions.":[405],"Additional":[406],"studies":[407],"underway":[409],"define":[411],"lymphoma-host":[413],"interactions":[414],"JAK":[419],"TKI":[420],"controlling":[422],"lymphoma":[424],"modulating":[428],"pro-tumorigenic":[430],"phenotype":[432],"Patient":[434],"Derived":[435],"Tumor":[436],"Xenograft":[437],"Citation":[438],"Format:":[439],"Ramona":[440],"Crescenzo,":[441],"Valentina":[442],"Fragliasso,":[443],"Marcello":[444],"Gaudiano,":[445],"Marco":[446],"Pizzi,":[447],"Giorgio":[448],"Inghirami.":[449],"Somatic":[450],"mutation":[451],"human":[461],"CD4-positive":[463],"favor":[466],"TCR-mediated":[467],"proliferation.":[468],"[abstract].":[469],"In:":[470],"Proceedings":[471],"107th":[474],"Annual":[475],"Meeting":[476],"American":[479],"Association":[480],"Cancer":[482,493],"Research;":[483],"2016":[484],"Apr":[485],"16-20;":[486],"New":[487],"Orleans,":[488],"LA.":[489],"Philadelphia":[490],"(PA):":[491],"AACR;":[492],"Res":[494],"2016;76(14":[495],"Suppl):Abstract":[496],"nr":[497],"2885.":[498]},"counts_by_year":[],"updated_date":"2026-10-09T09:14:12.587421","created_date":"2016-08-23T00:00:00"}